Objective To evaluate the level of arteriosclerosis in patients with hypertension defined by the American Heart Association (AHA) and classical diagnostic criteria. Methods A total of 3 815 residents were enrolled in 10 communities in north Shanghai. According to the classic diagnostic criteria of hypertension (systolic blood pressure≥140 mmHg and/or diastolic blood pressure≥90 mmHg) and AHA diagnostic criteria (systolic blood pressure≥130 mmHg and/or diastolic blood pressure≥80 mmHg), the population was divided into normal blood pressure group, AHA diagnosis standard hypertension group, and classic methods of diagnosis of hypertension group. The differences in cervical-femoral pulse wave velocity (cf-PWV) and brachial-ankle pulse wave velocity (ba-PWV) among the three groups were compared. SPSS 13.0 software was then used for data analysis.Results Compared with the patients who met the standard criteria, patients who met AHA criteria had lower mean ages (70.2±7.4 vs. 71.4±7.9 year, P<0.001), more history of hypertension (48.8% vs. 72.7%, P<0.001) and lower body mass index (24.1±3.5 vs. 24.7±3.9 kg/m2, P<0.001), low-density lipoprotein (3.07±0.92 vs. 3.15±0.97 mmol/L, P=0.033), cf-PWV (8.7±2.7 vs. 9.8±3.0 m/s, P<0.001) and ba-PWV (1 647.7±610.1 vs. 1 797.2±729.7 cm/s, P<0.001). Conclusions The degree of arteriosclerosis of patients who meet AHA standards is between that who meet the standard criteria and the normal population. For these patients, blood pressure should be actively controlled to delay the progression of arteriosclerosis.
Citation：
SONG Huahua, ZHAO Song, TANG Jiamin, JIA Dela, YANG Haotian, RU Sitanmujiang, ZHANG Yi, WANG Aiping. Arteriosclerosis in patients with hypertension defined by AHA and classical diagnostic criteria: a cross-sectional study. Chinese Journal of Evidence-Based Medicine, 2021, 21(10): 1122-1125. doi: 10.7507/1672-2531.202104069
Copy
Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved
| 1. |
田家瑞, 金石, 金铉顺. 2017年美国ACC/AHA高血压指南更新解读. 中国心血管病研究, 2018, 16(10): 885-888.
|
| 2. |
孙英贤, 李玉明, 蔡军, 等. 高血压合并动脉粥样硬化防治中国专家共识. 中华高血压杂志, 2020, 28(2): 116-123.
|
| 3. |
Qi Y, Han X, Zhao D, et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline. J Am Coll Cardiol, 2018, 72(11): 1201-1210.
|
| 4. |
Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24(4): 683-689.
|
| 5. |
Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document. J Hypertens, 2009, 27(11): 2121-2158.
|
| 6. |
Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American college of cardiology foundation/American heart association task force on Practice Guidelines. Circulation, 2010, 122(25): 2748-2764.
|
| 7. |
Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J, 2010, 31(19): 2338-2350.
|
| 8. |
Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J, 2006, 27(21): 2588-2605.
|
| 9. |
华琦, 谭静, 刘东霞, 等. 高血压病患者颈-股动脉和颈-桡动脉脉搏波速度改变及其影响因素. 中华心血管病杂志, 2005, 33(12): 1088-1091.
|
| 10. |
冯雪, 刘俊明. 脉搏波传导速度与高血压相关性的研究进展. 临床和实验医学杂志, 2013, 12(16): 1340-1341, 1343.
|
- 1. 田家瑞, 金石, 金铉顺. 2017年美国ACC/AHA高血压指南更新解读. 中国心血管病研究, 2018, 16(10): 885-888.
- 2. 孙英贤, 李玉明, 蔡军, 等. 高血压合并动脉粥样硬化防治中国专家共识. 中华高血压杂志, 2020, 28(2): 116-123.
- 3. Qi Y, Han X, Zhao D, et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline. J Am Coll Cardiol, 2018, 72(11): 1201-1210.
- 4. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24(4): 683-689.
- 5. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document. J Hypertens, 2009, 27(11): 2121-2158.
- 6. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American college of cardiology foundation/American heart association task force on Practice Guidelines. Circulation, 2010, 122(25): 2748-2764.
- 7. Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J, 2010, 31(19): 2338-2350.
- 8. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J, 2006, 27(21): 2588-2605.
- 9. 华琦, 谭静, 刘东霞, 等. 高血压病患者颈-股动脉和颈-桡动脉脉搏波速度改变及其影响因素. 中华心血管病杂志, 2005, 33(12): 1088-1091.
- 10. 冯雪, 刘俊明. 脉搏波传导速度与高血压相关性的研究进展. 临床和实验医学杂志, 2013, 12(16): 1340-1341, 1343.
